Veterinary Biomarkers Market Size, Share, Trends, Growth Outlook

According to USD Analytics the Global Veterinary Biomarkers Market is projected to register a 12.4% CAGR from 2025 to 2034

The global Veterinary Biomarkers Marketstudy analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Animal Type (Companion Animals, Production Animals), By Product (Biomarkers, Kits & Reagents, Biomarker Readers), By Application (Disease Diagnostics, Preclinical Research, Others), By Disease (Inflammatory & Infectious Diseases, Cardiovascular Diseases, Skeletal Muscle Diseases, Tumor, Others).

An introduction to Veterinary Biomarkers Market in 2025

The Veterinary Biomarkers Market focuses on the identification, validation, and application of biological markers in diagnosing diseases, monitoring treatment responses, and predicting outcomes in animals. Biomarkers, which can be proteins, nucleic acids, metabolites, or other molecules, provide valuable insights into the physiological and pathological processes occurring in animals, aiding veterinarians in disease detection, prognosis, and therapeutic decision-making. The veterinary biomarkers market encompasses a wide range of products and services, including diagnostic assays, laboratory tests, and research tools, offered by veterinary diagnostic companies, biotechnology firms, and contract research organizations. With the increasing demand for personalized veterinary medicine, precision diagnostics, and targeted therapies, the veterinary biomarkers market is poised for growth, driven by advancements in biomarker discovery, validation techniques, and molecular diagnostics technology.

Veterinary Biomarkers Market Trend: Increasing Focus on Precision Livestock Farming

One prominent trend in the Veterinary Biomarkers market is the increasing focus on precision livestock farming (PLF) practices, driving the demand for biomarkers for animal health monitoring and management. Precision livestock farming involves the use of advanced technologies and data analytics to monitor individual animal health, behavior, and performance in real-time, enabling proactive disease detection, early intervention, and optimized management practices. Biomarkers play a crucial role in PLF by serving as indicators of physiological processes, health status, and disease susceptibility in livestock species. With the growing emphasis on maximizing productivity, animal welfare, and sustainability in livestock production systems, there is a rising demand for biomarkers that provide valuable insights into animal health, performance, and stress responses, thereby driving market growth and innovation in the Veterinary Biomarkers market.

Veterinary Biomarkers Market Driver: Increasing Incidence of Infectious Diseases and Chronic Conditions in Animals

A significant driver in the Veterinary Biomarkers market is the increasing incidence of infectious diseases and chronic conditions in animals, necessitating the use of biomarkers for disease diagnosis, monitoring, and treatment evaluation. Livestock and companion animals are susceptible to a wide range of infectious pathogens, including bacteria, viruses, parasites, and fungi, which can cause significant economic losses and pose public health risks. Additionally, chronic conditions such as metabolic disorders, reproductive diseases, and musculoskeletal disorders affect animal health and productivity, requiring timely intervention and management strategies. Biomarkers provide valuable diagnostic information and prognostic insights into the underlying biological processes associated with disease progression, immune response, and treatment response in animals, driving the demand for biomarker-based diagnostic tests and assays in veterinary medicine. The increasing prevalence of infectious diseases and chronic conditions in animals serves as a key driver for market growth and investment in the Veterinary Biomarkers market.

Veterinary Biomarkers Market Opportunity: Development of Point-of-Care Biomarker Assays and Rapid Diagnostic Tests

An emerging opportunity in the Veterinary Biomarkers market lies in the development of point-of-care (POC) biomarker assays and rapid diagnostic tests for on-site animal health monitoring and disease management. Traditional laboratory-based biomarker assays often require specialized equipment, trained personnel, and lengthy turnaround times, limiting their utility in field settings, remote locations, and resource-limited environments. POC biomarker assays and rapid diagnostic tests offer advantages such as rapid results, simplicity of use, and portability, enabling veterinarians, livestock producers, and animal caregivers to perform rapid on-site testing for early disease detection, treatment monitoring, and decision-making. Manufacturers have the opportunity to innovate new POC biomarker assays and rapid diagnostic platforms that are user-friendly, cost-effective, and suitable for use in diverse animal species and production systems. By addressing the demand for POC biomarker testing solutions, stakeholders can enhance veterinary healthcare delivery, improve disease management outcomes, and capitalize on opportunities for market growth and innovation in the Veterinary Biomarkers market.

Veterinary Biomarkers Market Market Segmentation

By Animal Type
Companion Animals
-Dogs
-Cats
-Others
Production Animals
-Cows
-Pigs
-Others
By Product
Biomarkers, Kits & Reagents
Biomarker Readers
By Application
Disease Diagnostics
Preclinical Research
Others
By Disease Type
Inflammatory & Infectious Diseases
Cardiovascular Diseases
Skeletal Muscle Diseases
Tumor
Others

Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Veterinary Biomarkers Market Companies

Acuvet Biotech
Antech Diagnostics Inc
Avacta Animal Health Ltd
IDEXX Laboratories Inc
Life Diagnostics
Merck & Co. Inc
Mercodia AB
MI:RNA Diagnostics Ltd
Virbac
Zoetis

Reasons to Buy the Veterinary Biomarkers Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Veterinary Biomarkers Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Veterinary Biomarkers Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Veterinary Biomarkers Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Veterinary Biomarkers Market Size Outlook, $ Million, 2021 to 2030
3.2 Veterinary Biomarkers Market Outlook by Type, $ Million, 2021 to 2030
3.3 Veterinary Biomarkers Market Outlook by Product, $ Million, 2021 to 2030
3.4 Veterinary Biomarkers Market Outlook by Application, $ Million, 2021 to 2030
3.5 Veterinary Biomarkers Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Veterinary Biomarkers Industry
4.2 Key Market Trends in Veterinary Biomarkers Industry
4.3 Potential Opportunities in Veterinary Biomarkers Industry
4.4 Key Challenges in Veterinary Biomarkers Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Veterinary Biomarkers Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Veterinary Biomarkers Market Outlook by Segments
7.1 Veterinary Biomarkers Market Outlook by Segments, $ Million, 2021- 2030
By Animal Type
Companion Animals
-Dogs
-Cats
-Others
Production Animals
-Cows
-Pigs
-Others
By Product
Biomarkers, Kits & Reagents
Biomarker Readers
By Application
Disease Diagnostics
Preclinical Research
Others
By Disease Type
Inflammatory & Infectious Diseases
Cardiovascular Diseases
Skeletal Muscle Diseases
Tumor
Others

8 North America Veterinary Biomarkers Market Analysis and Outlook To 2030
8.1 Introduction to North America Veterinary Biomarkers Markets in 2024
8.2 North America Veterinary Biomarkers Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Veterinary Biomarkers Market size Outlook by Segments, 2021-2030
By Animal Type
Companion Animals
-Dogs
-Cats
-Others
Production Animals
-Cows
-Pigs
-Others
By Product
Biomarkers, Kits & Reagents
Biomarker Readers
By Application
Disease Diagnostics
Preclinical Research
Others
By Disease Type
Inflammatory & Infectious Diseases
Cardiovascular Diseases
Skeletal Muscle Diseases
Tumor
Others

9 Europe Veterinary Biomarkers Market Analysis and Outlook To 2030
9.1 Introduction to Europe Veterinary Biomarkers Markets in 2024
9.2 Europe Veterinary Biomarkers Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Veterinary Biomarkers Market Size Outlook by Segments, 2021-2030
By Animal Type
Companion Animals
-Dogs
-Cats
-Others
Production Animals
-Cows
-Pigs
-Others
By Product
Biomarkers, Kits & Reagents
Biomarker Readers
By Application
Disease Diagnostics
Preclinical Research
Others
By Disease Type
Inflammatory & Infectious Diseases
Cardiovascular Diseases
Skeletal Muscle Diseases
Tumor
Others

10 Asia Pacific Veterinary Biomarkers Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Veterinary Biomarkers Markets in 2024
10.2 Asia Pacific Veterinary Biomarkers Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Veterinary Biomarkers Market size Outlook by Segments, 2021-2030
By Animal Type
Companion Animals
-Dogs
-Cats
-Others
Production Animals
-Cows
-Pigs
-Others
By Product
Biomarkers, Kits & Reagents
Biomarker Readers
By Application
Disease Diagnostics
Preclinical Research
Others
By Disease Type
Inflammatory & Infectious Diseases
Cardiovascular Diseases
Skeletal Muscle Diseases
Tumor
Others

11 South America Veterinary Biomarkers Market Analysis and Outlook To 2030
11.1 Introduction to South America Veterinary Biomarkers Markets in 2024
11.2 South America Veterinary Biomarkers Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Veterinary Biomarkers Market size Outlook by Segments, 2021-2030
By Animal Type
Companion Animals
-Dogs
-Cats
-Others
Production Animals
-Cows
-Pigs
-Others
By Product
Biomarkers, Kits & Reagents
Biomarker Readers
By Application
Disease Diagnostics
Preclinical Research
Others
By Disease Type
Inflammatory & Infectious Diseases
Cardiovascular Diseases
Skeletal Muscle Diseases
Tumor
Others

12 Middle East and Africa Veterinary Biomarkers Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Veterinary Biomarkers Markets in 2024
12.2 Middle East and Africa Veterinary Biomarkers Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Veterinary Biomarkers Market size Outlook by Segments, 2021-2030
By Animal Type
Companion Animals
-Dogs
-Cats
-Others
Production Animals
-Cows
-Pigs
-Others
By Product
Biomarkers, Kits & Reagents
Biomarker Readers
By Application
Disease Diagnostics
Preclinical Research
Others
By Disease Type
Inflammatory & Infectious Diseases
Cardiovascular Diseases
Skeletal Muscle Diseases
Tumor
Others

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Acuvet Biotech
Antech Diagnostics Inc
Avacta Animal Health Ltd
IDEXX Laboratories Inc
Life Diagnostics
Merck & Co. Inc
Mercodia AB
MI:RNA Diagnostics Ltd
Virbac
Zoetis
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Animal Type
Companion Animals
-Dogs
-Cats
-Others
Production Animals
-Cows
-Pigs
-Others
By Product
Biomarkers, Kits & Reagents
Biomarker Readers
By Application
Disease Diagnostics
Preclinical Research
Others
By Disease Type
Inflammatory & Infectious Diseases
Cardiovascular Diseases
Skeletal Muscle Diseases
Tumor
Others